(Q54056099)

24 May 2018

title

The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study. (English)

1 reference

24 May 2018

1 reference

S E Lawson

1

1 reference

24 May 2018

G Harrison

2

1 reference

24 May 2018

S Richards

3

1 reference

24 May 2018

A Oakhill

4

1 reference

24 May 2018

R Stevens

5

1 reference

24 May 2018

O B Eden

6

1 reference

24 May 2018

P J Darbyshire

7

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 March 2000

1 reference

24 May 2018

British Journal of Haematology

published in

1 reference

24 May 2018

volume

108

1 reference

24 May 2018

issue

3

1 reference

24 May 2018

page(s)

531-543

1 reference

24 May 2018

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Bone marrow relapse occurring as first relapse in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Which treatment for childhood acute lymphoblastic leukaemia in second remission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

A second course of treatment for childhood acute lymphoblastic leukaemia: long-term follow-up is needed to assess results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Autologous bone marrow transplantation for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Treatment of isolated testicular relapse in childhood acute lymphoblastic leukemia: an Italian multicenter study. Associazione Italiana Ematologia ed Oncologia Pediatrica

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: risk factors and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2000.01891.X

10.1046/J.1365-2141.2000.01891.X

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018